Clinical trial
A Long Term Study of Clozapine in Patients With Treatment-resistant…
NCT00154258 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00154258 |
|---|---|
| Title | A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia |
| Official title | An Open Extension Study to Phase IIb Study of Clozapine in Patients With Treatment-resistant Schizophrenia |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Clozapine |
| Enrollment | 19 |
| Start date | Apr 1, 2001 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 24, 2020 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: